Overview

Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test higher versus lower doses of aspirin on markers of atherosclerosis in patients at risk of a first heart attack.
Phase:
Phase 4
Details
Lead Sponsor:
Florida Atlantic University
Collaborator:
Bayer
Treatments:
Aspirin